Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06264752 · ClinicalTrials.gov registry record · NA

Multi-hospital Electronic Decision Support for Drug-associated Acute Kidney Injury

A NA study, sponsored by University of Pittsburgh.

Completed
Registry status
NA
Development phase
698
Enrollment target

NCT06264752 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 698 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06264752, a NA study, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
NA
Development phase
698 participants
Enrollment target

Study Summary

This study is a randomized controlled trial at eight hospitals within the University of Pittsburgh Medical Center-UPMC system. The project will assess the efficacy of a clinical surveillance system augmented with near real-time predictive analytics to support a pharmacist-led intervention delivered to attending physicians (primary service) to reduce the progression and complications of drug-associated acute kidney injury (D-AKI) in hospitalized (non-ICU) adults.

Interventions

  • OTHER Level A
  • OTHER Level B
  • OTHER Passive Alert

Trial Details

FieldValue
Enrollment Target 698 participants
Start Date 2024-02-15
Est. Completion 2025-07-15
Phase NA

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT06264752

The ClinicalTrials.gov registry entry for NCT06264752 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 698 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Level A is the first listed.

NCT06264752 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06264752 about?

NCT06264752 is a clinical study titled "Multi-hospital Electronic Decision Support for Drug-associated Acute Kidney Injury". This study is a randomized controlled trial at eight hospitals within the University of Pittsburgh Medical Center-UPMC system. The project will assess the efficacy of a clinical surveillance system augmented with near real-time predictive analytics to support a pharmacist-led intervention delivered ...

What is the current status of trial NCT06264752?

This trial is currently completed. It is a NA study. The enrollment target is 698 participants. The study started on 2024-02-15. Estimated completion is 2025-07-15.

What interventions are being tested in trial NCT06264752?

The interventions under investigation include: Level A (OTHER), Level B (OTHER), Passive Alert (OTHER).

Who is sponsoring clinical trial NCT06264752?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.